BBA
AVNR

Baker Bros. Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Baker Bros. Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,356,200
Closed -$112M – 122
2014
Q3 		$112M Buy
+9,356,200
New +$63.9M 1.4% 13

Baker Bros. Advisors's AVNR Position: Q1 2015 in Review

Baker Bros. Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 38,513,713 shares — an estimated $653M sold.

Baker Bros. Advisors first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $653M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Baker Bros. Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Baker Bros. Advisors sold 38,513,713 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $653M.
  • Baker Bros. Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Baker Bros. Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $653M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Baker Bros. Advisors's 13F filing for Q1 2015, filed 15 May 2015.